Nuventra to Present on QSP and PBPK at the 2020 ACCP Virtual Roundtable
Salil Pendse, M.S., who recently joined Nuventra as a Quantitative Systems Pharmacologist, will present a roundtable discussion titled, “An Overview of QSP and PBPK: Modeling Biology in Drug Development,” at this…
Read More
Nuventra Ranks on Inc. 5000 List for Seventh Consecutive Year
Inc. Magazine revealed today that Nuventra Pharma Sciences has once again ranked on the Inc. 5000 list for 2020. This marks the seventh year in a row that Nuventra has…
Read More
Former FDA Reviewer Suliman Al-Fayoumi Joins Nuventra Pharma Sciences as Senior Consultant
Nuventra Pharma Sciences is pleased to announce the addition of Suliman Al-Fayoumi, PhD, MBA, to its growing team of experienced consultants. Dr. Al-Fayoumi has more than 20 years of experience…
Read More
Nuventra’s Brandon Burch to Speak at DIA 2020 Virtual Annual Meeting
Nuventra’s Associate Director of Scientific Writing and Regulatory Affairs, Brandon Burch, Ph.D., will present during the session titled, “Storyboarding for Key Message Alignment in Marketing Applications” at this years’ DIA…
Read More
Nuventra Scientists Publish Manuscript Discussing the Feasibility of Ivermectin as a Treatment for SARS-CoV-2
Durham, NC – Nuventra’s Virginia (Ginny) Schmith, Ph.D., FCP, Jie (Jessie) Zhou, Ph.D., and Lauren Lohmer, Ph.D., have written a manuscript discussing the feasibility of using ivermectin as a treatment for…
Read More
Statement in Response to COVID-19 from Nuventra Pharma Sciences
Durham, NC – As a company committed to helping our clients bring new medicines to patients in need, we have been closely monitoring the global spread of the novel coronavirus…
Read More
Nuventra’s Brian Furmanski to Speak at the Drug Metabolism Discussion Group Winter Symposium
Nuventra’s Brian Furmanski, PhD, will be speaking at this year’s Drug Metabolism Discussion Group (DMDG) Winter Symposium on February 27th at the Solution Center in Research Triangle Park, NC. Brian’s…
Read More